Realizing the potential of clean mastered data for businesses

As the center of gravity for enterprise data moves to the cloud, modern data driven enterprises are just beginning to scratch the surface of their newfound, highly elastic scalable compute and persistence resources that are necessary to accelerate digital transformations.…

The amount of clinical data is compounding at an astonishing rate. Largely, this is due to our increased ability to generate and collect vast amounts of data that was previously left untouched. While this new data holds tons of potential,…

Ontologies are used across industries in order to share information in a standardized manner. At its core, an ontology is a shared, explicit and formal domain model for representing entities in one’s data and organization, and it serves as a…

Our big inaugural event, DataMasters Summit wrapped this month. Hundreds of people registered to listen to more than 25 original presentations by some of the most important and influential voices in data. We featured speakers from Government, Financial Services, Life…

A Conversation with Andy Palmer, Tamr’s CEO, and Anthony Deighton, Tamr’s Chief Product Officer“There are two things that really matter in AI systems. One is having enough great data to make an algorithm useful. And the other one is the…

Leading organizations are leveraging an analytics-driven approach—fueled and informed by data—to achieve marketplace advantages and create entirely new business models. However, even the savviest companies are repeating common missteps. I recently gave a presentation on this very topic at the…

If you’re reading this, hopefully you’re already a fan of Tamr’s DataMasters podcast. But there are a wealth of great data and analytics podcasts out there, and we wanted to share a few that we think are some of the…

Last week, Suki Dhuphar and I talked about the surge of new public cloud-partnerships with financial services that took place in July (HSBC & AWS, National Australia Bank & Azure, Deutsche Bank & GCP). While the month appears to have…

Today it can take up to $2.6bn and 14 years to move a drug from “bench-to-bedside.” While over the past decades, our medical knowledge and research and development capabilities have advanced exponentially—drug development remains incredibly hard and costly. One of…

What does digital transformation mean to you and what’s the role of managing data as an asset in that context? This was the first in a series of questions Andy Palmer, Co-Founder and CEO at Tamr, asked Mona Vernon, Head…